EnzymeBioSystems engages in manufacturing specialty enzymes and enzyme related products. The company utilizes enzyme technologies to develop commercial solutions for applications within the specialty chemical industry. It plans to work collaboratively with industrial companies to develop differentiated enzyme solutions for target markets. The company serves businesses and research university centers. EnzymeBioSystems was founded on June 26, 2009 and is headquartered in Las Vegas, NV.
Company profile
Website
CEO
John Dean Harper
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Enzyme Bio Systems
SEC CIK
Corporate docs
Latest filings (excl ownership)
15-12G/A
Securities registration termination (amended)
17 Sep 18
15-12G
Securities registration termination
14 Sep 18
10-Q
2018 Q3
Quarterly report
8 May 18
RW WD
Withdrawal of registration withdrawal request
20 Mar 18
RW
Registration withdrawal request
16 Mar 18
10-Q
2018 Q2
Quarterly report
21 Feb 18
NT 10-Q
Notice of late quarterly filing
14 Feb 18
S-1/A
IPO registration (amended)
6 Feb 18
S-1/A
IPO registration (amended)
25 Jan 18
S-1
IPO registration
11 Jan 18
Institutional ownership, Q3 2019
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|